OWD
TMO icon

Osborn Williams & Donohoe’s Thermo Fisher Scientific TMO Stock Holding History

Osborn Williams & Donohoe’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$3.19M Buy
11,235
+340
+3% +$107K 0.42% 66
2019
Q4 		$3.54M Sell
10,895
-2,813
-21% -$853K 0.35% 81
2019
Q3 		$3.99M Buy
13,708
+602
+5% +$172K 0.4% 71
2019
Q2 		$3.85M Buy
13,106
+666
+5% +$183K 0.4% 72
2019
Q1 		$3.49M Buy
12,440
+7,175
+136% +$1.79M 0.36% 80
2018
Q4 		$1.18M Sell
5,265
-100
-2% -$23.5K 0.21% 107
2018
Q3 		$1.31M Sell
5,365
-45
-0.8% -$10.4K 0.2% 107
2018
Q2 		$1.12M Buy
5,410
+17
+0.3% +$3.61K 0.19% 110
2018
Q1 		$1.11M Buy
5,393
+2
+0% +$420 0.19% 108
2017
Q4 		$1.02M Buy
5,391
+15
+0.3% +$2.87K 0.18% 111
2017
Q3 		$1.02M Sell
5,376
-40
-0.7% -$7.24K 0.18% 106
2017
Q2 		$945K Sell
5,416
-50
-0.9% -$8.4K 0.17% 112
2017
Q1 		$840K Sell
5,466
-25
-0.5% -$3.82K 0.15% 121
2016
Q4 		$775K Hold
5,491
– – 0.15% 124
2016
Q3 		$873K Buy
5,491
+40
+0.7% +$6.16K 0.17% 118
2016
Q2 		$805K Sell
5,451
-254
-4% -$37.5K 0.16% 115
2016
Q1 		$808K Sell
5,705
-50
-0.9% -$6.7K 0.16% 118
2015
Q4 		$816K Sell
5,755
-75
-1% -$10K 0.17% 115
2015
Q3 		$715K Hold
5,830
– – 0.16% 118
2015
Q2 		$804K Sell
5,830
-250
-4% -$32.6K 0.16% 117
2015
Q1 		$817K Sell
6,080
-630
-9% -$81.2K 0.16% 122
2014
Q4 		$841K Sell
6,710
-225
-3% -$27.4K 0.16% 114
2014
Q3 		$844K Sell
6,935
-100
-1% -$12.2K 0.18% 111
2014
Q2 		$832K Hold
7,035
– – 0.17% 113
2014
Q1 		$846K Sell
7,035
-950
-12% -$113K 0.19% 103
2013
Q4 		$889K Sell
7,985
-50
-0.6% -$4.97K 0.2% 101
2013
Q3 		$740K Hold
8,035
– – 0.18% 108
2013
Q2 		$680K Buy
+8,035
New +$669K 0.18% 110

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Osborn Williams & Donohoe's TMO Position: Q1 2020 in Review

Osborn Williams & Donohoe increased its Thermo Fisher Scientific (TMO) stake by 3.1% in Q1 2020, buying an estimated $107K and bringing the position to 11,235 shares worth $3.19M. The position accounts for 0.42% of the portfolio, ranked #66.

Osborn Williams & Donohoe first reported a position in TMO in Q2 2013 and has held it in 28 quarters since. The position peaked at $3.99M in Q3 2019. 1,674 funds tracked by Wall St. Rank hold TMO as of Q1 2020.

  • Osborn Williams & Donohoe held 11,235 shares of Thermo Fisher Scientific worth $3.19M as of Q1 2020.
  • Osborn Williams & Donohoe bought 340 Thermo Fisher Scientific shares in Q1 2020, an estimated $107K.
  • Thermo Fisher Scientific made up 0.42% of Osborn Williams & Donohoe's portfolio in Q1 2020, its #66 holding.
  • Osborn Williams & Donohoe first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 28 quarters since.
  • Osborn Williams & Donohoe's Thermo Fisher Scientific position peaked at $3.99M in Q3 2019.
  • 1,674 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2020.

Based on Osborn Williams & Donohoe's 13F filing for Q1 2020, filed 4 May 2020.